A class of designs for Phase I cancer clinical trials combining Bayesian and likelihood approaches

DOI10.1080/02664763.2010.505955zbMath1218.62119OpenAlexW2028645887MaRDI QIDQ3019496

Zheng Su

Publication date: 28 July 2011

Published in: Journal of Applied Statistics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/02664763.2010.505955

zbMATH Keywords

maximum likelihoodBayesiandose escalationMTD

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Bayesian inference (62F15) Medical applications (general) (92C50)

Related Items (1)

Adaptive clinical trial designs for phase I cancer studies

Cites Work

• Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
• Design and Analysis of Phase I Clinical Trials
• Continual Reassessment Method: A Likelihood Approach
• Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials

This page was built for publication: A class of designs for Phase I cancer clinical trials combining Bayesian and likelihood approaches